Trial Outcomes & Findings for The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial (NCT NCT02482025)
NCT ID: NCT02482025
Last Updated: 2020-11-19
Results Overview
Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record
COMPLETED
NA
240 participants
30 days after hospitalization
2020-11-19
Participant Flow
Participant milestones
| Measure |
Usual Care
Usual care delivered at VA Boston
|
SMMRT
Receives Usual Care PLUS SMMRT Intervention
SMMRT: Includes My HealtheVet registration and enrollment
|
|---|---|---|
|
Overall Study
STARTED
|
122
|
118
|
|
Overall Study
COMPLETED
|
122
|
118
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
Baseline characteristics by cohort
| Measure |
Usual Care
n=122 Participants
Usual care delivered at VA Boston
|
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention
SMMRT: Includes My HealtheVet registration and enrollment
|
Total
n=240 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
66.1 years
STANDARD_DEVIATION 11.8 • n=5 Participants
|
63.4 years
STANDARD_DEVIATION 11.7 • n=7 Participants
|
64.9 years
STANDARD_DEVIATION 11.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
112 Participants
n=5 Participants
|
110 Participants
n=7 Participants
|
222 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · White
|
104 Participants
n=5 Participants
|
100 Participants
n=7 Participants
|
204 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race · Non-White
|
18 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
36 Participants
n=5 Participants
|
|
MyHealtheVet: Yes, No
My HealtheVet - Yes
|
107 Participants
n=5 Participants
|
105 Participants
n=7 Participants
|
212 Participants
n=5 Participants
|
|
MyHealtheVet: Yes, No
My HealtheVet - No
|
15 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 days after hospitalizationPopulation: Intention to treat.
Medication discrepancies (discrepancies between what the patient is taking and what is in the medical record) identified 30 days after hospitalization via telephone interview and review of medical record
Outcome measures
| Measure |
Usual Care
n=122 Participants
Usual care delivered at VA Boston
|
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention
SMMRT: Includes My HealtheVet registration and enrollment
|
|---|---|---|
|
Medication Discrepancies
|
6.4 Medication Discrepancies
Standard Deviation 4.6
|
4.4 Medication Discrepancies
Standard Deviation 3.2
|
SECONDARY outcome
Timeframe: 30 daysPopulation: Intention to Treat.
Hospital utilization, defined as re-admissions or emergency department utilization, within 30 days of hospital discharge.
Outcome measures
| Measure |
Usual Care
n=122 Participants
Usual care delivered at VA Boston
|
SMMRT
n=118 Participants
Receives Usual Care PLUS SMMRT Intervention
SMMRT: Includes My HealtheVet registration and enrollment
|
|---|---|---|
|
Hospital Utilization
|
41 Participants
|
35 Participants
|
Adverse Events
Usual Care
SMMRT
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Steven R. Simon, MD
VA Greater Los Angeles Healthcare System
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place